Why Tempus ai (tem) now skyrocket

We recently put together a list of the Why these 15 shares in 2025 skyrocket. In this article we will take a look at where Tempus Ai (Nasdaq: TEM) stands against the other shares.

People always make it to speech and in 2025 there is no exception. The markets have increased higher for a while due to a shift towards technical innovation. The pace could slow down after two years of considerable returns, but investors have regained their trust after the Stargate project has been announced.

Small and medium-sized companies have recently started to increase speed and end up on the radar radars, since MEGA cap shares are now being traded with nosebleeds. These companies have a higher growth potential than their mega cap competitors, and that explains the sudden interest.

In earlier years, small and medium -sized stocks were faced with challenges in which corrections and interest rate increases on the market mood. Now that inflation is more contained and Trump is pushing for more tariff shortcuts, things look even better for these medium -sized shares.

methodology

For this article, I examined the high-quality shares from year to year in the market capitalization class from $ 5 billion to $ 20 billion. Shares that I have covered recently are excluded from this list.

I will also mention the number of hedge fund investors in these shares. Why are we interested in the shares that invest hedge funds? The reason is simple: Our research has shown that we can outperform the market by imitating the top shares selection of the best hedge funds. The strategy of our quarterly newsletter selects 14 small cap and large cap shares per quarter and has been returned 275% since May 2014, whereby the benchmark is surpassed by 150 percentage points. (You can find more information here).

A patient who looks at their medical diagnosis in an ecosystem for digital healthcare.

Number of hedge fund owners in Q3 2024: 7

Tempus AI (Nasdaq: TEM) is a healthcare company that uses AI for sequencing tests and has a data platform.

So far, it has risen considerably in 2025, mainly due to Nancy Pelosi that you bought 50 call options here at an exercise price of 20 US dollars. The company also has a concierge app called Olivia. Many now think that the AI ​​topic spills into health care, especially since it was mentioned a lot during the Stargate announcement.

Tempus’ recent preliminary financial data for 2024 showed annual sales of $ 693 million of 30%compared to the previous year. It also achieved sales of 200 million US dollars in the fourth quarter. Genomics rose by 30% in the fourth quarter and the turnover of data and services by 45%. Nevertheless, there was a certain softness in the work of the contractual research organization.

The story continues